Health committee  It has been one of the problems, actually, because some of the people who really don't believe in the association of CCSVI have put forth exactly this observation: Why is it that so many patients have the same abnormalities in their vein system and don't show the MS symptoms? We could discuss at length the various reasons for that.

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  

Questions Passed as Orders for Returns  With respect to chronic cerebrospinal venous insufficiency (CCSVI): (a) do the Canadian Institutes of Health Research (CIHR) or Health Canada recognize the Consensus Document of the International Union of Phlebology (IUP) on the diagnosis and treatment of venous malformations, in which CCSVI is recognized as venous truncular lesions obstructing the main outflow routes from the central nervous system; (b) does CIHR or Health Canada recognize the recommendations by the IUP expert panel for therapeutic interventions, including angioplasty, stenting, or open surgical repair of the lesions, in proven CCSVI cases; (c) did anyone from CIHR or Health Canada attend the July 26, 2010 CCSVI Professional Symposium and, if not, (i) was there a review of the findings of the Symposium, (ii) was the review included in the process for the August 26, 2010 meeting between CIHR and the Multiple Sclerosis Society of Canada (MSSC); (d) what were the terms of reference for the August 26, 2010 meeting between CIHR and the MSSC; (e) in detail, what were the steps taken in the review of the current state of CCSVI science for the August 26 meeting and, specifically, (i) were international experts outside of the United States consulted, (ii) what process was undertaken to ensure fair and unbiased reviewers, (iii) what check of reviewers’ backgrounds was undertaken regarding links to specific organizations, review panels and grants obtained, (iv) which, if any, of the reviewers had previously spoken for or against the CCSVI theory or liberation procedure, (v) were reviewers who had experience or expertise with CCSVI selected and, if not, why not, (vi) which, if any, of the reviewers declared a conflict of interest, (vii) what, if any, action was taken to address any identified conflict of interest; (f) did the Health Minister review the biographies of the committee members for the August 26 meeting (i) if not, why, (ii) if so, were any problems identified and any action taken; (g) what published papers were reviewed by panel members, broken down by (i) those that confirm venous malformations in Multiple Sclerosis (MS) patients, (ii) those that deny venous malformations in MS patients, (iii) those that neither confirm nor deny venous malformations in MS patients; (h) were international practitioners, such as those in Bulgaria, Italy, Kuwait and the United States, consulted to learn (i) how many liberation procedures they had undertaken, (ii) what, if any, improvements their patients experienced, particularly in relation to fatigue, "brain fog", motor skills, and Expanded Disability Status Score; (i) what were the details of the agenda for the August 26, 2010 meeting; (j) what will be the process for establishing the CCSVI working group, announced August 31, 2010, and (i) will it be an open or closed process, (ii) will it include CCSVI and liberation procedure experts from Canada, such as Dr.

Supporting Vulnerable Seniors and Strengthening Canada's Economy Act  The government has been made aware that over 12,500 treatment procedures for chronic cerebrospinal venous insufficiency, or CCSVI, have now been undertaken worldwide in over 50 countries and that some MS patients report improved quality of life, including reduced brain fog, fatigue, improved circulation and motor skills following the procedure.